Migraine Treatment Market: Major Trends Reshaping the Future of the Industry

Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.

What Will the Migraine Treatment Industry Market Size Be by 2025?
In recent times, the market for migraine treatments has been seeing robust growth. It is anticipated to expand from $3.18 billion in 2024 to $3.48 billion in 2025, reflecting a compound annual growth rate (CAGR) of 9.4%. The past growth in this market has been attributed to factors such as rises in incidences of migraine, augmented healthcare expenditure, enhancement in the formulations of existing medications, growth in clinical research, and the emergence of new treatment strategies.

What's the Long-Term Growth Forecast for the Migraine Treatment Market Size Through 2029?
The market for migraine treatment is predicted to expand rapidly in the coming years. It will reach a value of $5.32 billion by 2029, with a compound annual growth rate (CAGR) of 11.2%. This growth through the forecast period can be linked to increasing education and consciousness, the advent of monoclonal antibodies, a heightened focus on pediatric migraines, and the expansion of non-pharmaceutical interventions, as well as global efforts toward migraine research. Key trends for this period include progress in therapeutic strategies, uses of wearable and digital therapeutic devices, the rise of telemedicine and virtual consultations, patient-oriented care models, the growth in the market for generic drugs, and oral CGRP inhibitors.

View the full report here:
https://www.thebusinessresearchcompany.com/report/migraine-treatment-global-market-report

What Are the Key Growth Drivers Fueling the Migraine Treatment Market Expansion?
The surge in the migraine treatment market can be accounted to the extended exposure to screens. When we talk about screen exposure, it refers to how much time a person spends with electronic screens like smartphones, tablets, computers, and televisions. This excessive exposure is mainly due to increased work from home, digital learning, digital entertainment, and the increased dependency on technology for maintaining social relationships. Migraine treatments control migraine symptoms that are induced or worsened by prolong screen exposure and this includes medication, changes in lifestyle, and proper ergonomic practices to reduce strain and prevent migraines. In May 2024, data from the UK-based Parliament health agency, the House of Commons Committee, stated that in the year 2021, the screen time for children had surged by 52% in 2022, revealing that about 25% of the young population displayed smartphone usage habits that correlate with behavioral addiction. This implies that the growth of the migraine treatment market is fueled by prolonged screen exposure.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8126&type=smp

What Are the Key Trends Driving Migraine Treatment Market Growth?
The primary trend gaining traction in the migraine treatment market is product innovation. Companies leading this market are incorporating novel developments like liquid formulations to retain their market standing. In January 2022, for example, BioDelivery Sciences International (BDSI), a pharmaceutical company from the U.S., unveiled Elyxyb (celecoxib oral solution) for the acute treatment of migraines in adults, irrespective of aura experience. Its liquid formulation ensures swift absorption in the small intestine, providing quicker relief than standard tablets. This is especially advantageous for individuals suffering from migraines who also experience nausea or vomiting, as they no longer have to wait for a pill to dissolve. Elyxyb stands as the first and only FDA-approved oral solution ready for use in treating migraines, presenting a more effective and tolerable solution for managing the sudden, severe pain that migraines entail.

How Is the Migraine Treatment Market Segmented?
The migraine treatment market covered in this report is segmented -

1) By Types: Episodic, Migraine With Aura, Chronic, Other Types
2) By Treatment: Acute Or Abortive Treatment, Preventive Or prophylactic Treatment, Non-Pharmacological Therapies And Devices
3) By End-User: Hospitals, Clinics, Homecare, Other End-users

Subsegments:
1) By Episodic: Frequent Episodic Migraine, Infrequent Episodic Migraine
2) By Migraine With Aura: Visual Aura, Sensory Aura, Speech Or Language Aura
3) By Chronic: Chronic Migraine Without Aura, Chronic Migraine With Aura
4) By Other Types: Hemiplegic Migraine, Retinal Migraine, Menstrual Migraine, Other Specific Types

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=8126&type=smp

Which Companies Are Leading the Charge in Migraine Treatment Market Innovation?
Major companies operating in the migraine treatment market are Pfizer Inc., Eli Lilly and Company, Amgen Inc., GlaxoSmithKline PLC, Novartis AG, Bayer AG, Allergan PLC, Abbott Laboratories, Allodynic Therapeutics LLC, AOBiome LLC, AstraZeneca PLC, Bausch Health Companies Inc., Boehringer Ingelheim International GmbH, Dr. Reddy's Laboratories Limited, Impel Pharmaceuticals Inc., AbbVie Inc., Alder BioPharmaceuticals Inc., Astellas Pharma Inc., Biohaven Pharmaceutical Holding Company Ltd., Bristol-Myers Squibb Company, Daiichi Sankyo Company Limited, Eisai Co. Ltd., Endo International PLC, Impax Laboratories Inc., Johnson & Johnson Inc., Lannett Company Inc., Lupin Limited, Merck & Co. Inc., Mylan N.V.

Which Regions Are Leading the Global Migraine Treatment Market in Revenue?
North America was the largest region in the migraine treatment market in 2024. The regions covered in the migraine treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8126

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.